LEADER 04756nam  22006495  450 
001 9910298284303321
005 20200630161102.0
010   $a94-017-9421-9
024 7 $a10.1007/978-94-017-9421-3
035   $a(CKB)3710000000277699
035   $a(EBL)1966690
035   $a(OCoLC)894893487
035   $a(SSID)ssj0001385875
035   $a(PQKBManifestationID)11833679
035   $a(PQKBTitleCode)TC0001385875
035   $a(PQKBWorkID)11341378
035   $a(PQKB)10996521
035   $a(DE-He213)978-94-017-9421-3
035   $a(MiAaPQ)EBC1966690
035   $a(PPN)183088786
035   $a(EXLCZ)993710000000277699
100   $a20141107d2015      u|             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aStress Response Pathways in Cancer$b[electronic resource] $eFrom Molecular Targets to Novel Therapeutics /$fedited by Georg T. Wondrak
205   $a1st ed. 2015.
210  1$aDordrecht :$cSpringer Netherlands :$cImprint: Springer,$d2015.
215   $a1 online resource (450 p.)
300   $aDescription based upon print version of record.
311   $a94-017-9420-0 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aPreface -- Introduction to cell stress responses in cancer: The big picture -- DNA repair dysregulation in cancer: From molecular mechanisms to synthetic-lethal opportunities -- Cell cycle checkpoint defects as anticancer targets: From molecular mechanisms to therapeutic opportunities -- p53 at the crossroads between stress response signaling and tumorigenesis: From molecular mechanisms to therapeutic opportunities -- Sirtuins as a double-edged sword in cancer: From molecular mechanisms to therapeutic opportunities -- MicroRNA regulated stress responses in cancer -- Senescence in oncogenesis: From molecular mechanisms to therapeutic opportunities -- Pro-senescence therapy for cancer: time for the clinic -- Integrating proteotoxic stress response pathways for induction of cell death in cancer cells: molecular mechanisms and opportunities -- The Hsp70 family of heat shock proteins in tumorigenesis: From molecular mechanisms to therapeutic opportunities -- The ubiquitin-proteasome system (UPS) as a cancer drug target: Emerging mechanisms and therapeutics -- Endoplasmatic reticulum stress in multiple myeloma: From molecular mechanisms to therapeutic opportunities -- Melanomagenic gene alterations viewed from a redox perspective: Molecular mechanisms and therapeutic opportunities -- Targeting hypoxic adaptations of cancer cells: Molecular mechanisms and therapeutic opportunities -- Targeting glycolytic adaptations of cancer cells: from molecular mechanisms to therapeutic opportunities -- At the crossroads between mitochondrial metabolite transport and apoptosis: VDAC1 as an emerging cancer drug target -- Inflammatory dysregulation and cancer: From molecular mechanisms to therapeutic opportunities -- Cell-nonautonomous ER stress-mediated dysregulation of immunity by cancer cells -- Index.
330   $aIt is now established that dysregulated cell stress response pathways play a critical role in tumorigenesis, and a refined mechanistic understanding of this phenomenon at the molecular level promises to open new avenues for targeted therapeutic strategies that may benefit cancer patients in the near future. Coauthored by recognized leaders in cancer research from five continents, this novel book provides a comprehensive perspective on cell stress response pathways and therapeutic opportunities. Focusing on the role of genotoxic, proteotoxic, oxidative, metabolic, and inflammatory stress in tumorigenesis, the book is essential reading for students, basic researchers, and biomedical health care professionals interested in cancer and therapeutic development.
606   $aCancer research
606   $aCell biology
606   $aOncology  
606   $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001
606   $aCell Biology$3https://scigraph.springernature.com/ontologies/product-market-codes/L16008
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
615  0$aCancer research.
615  0$aCell biology.
615  0$aOncology  .
615 14$aCancer Research.
615 24$aCell Biology.
615 24$aOncology.
676   $a571.6
676   $a610
676   $a614.5999
676   $a616994
702   $aWondrak$b Georg T$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910298284303321
996   $aStress Response Pathways in Cancer$92502126
997   $aUNINA